期刊选题

1、投稿方式：在线投稿。

2、刊内网址：http://www.jbr-pub.org.cn

投稿系统：

https://mc03.manuscriptcentral.com/jbrint

3、刊内邮箱：jbr@njmu.edu.cn

4、刊内电话：025-86869291

5、出刊日期：双月刊，逢单月15日出版。

2021年5月12日星期三

《生物医学研究杂志（英文）》投稿指南

【官网信息】

Guide to Authors

Scope and Aim

The

Journal of Biomedical Research (JBR), a peer-reviewed open access

publication, intends to provide international biomedical researchers and

clinicians with an open forum to disseminate important new information

in all aspects of experimental and clinical medicine. JBR is covered by

major abstracting and indexing services and welcomes submissions from

authors worldwide. Six issues annually feature original research

articles, review articles, case reports, and Letter to the Editor. The

Journal also accepts perspective articles on medicolegal and

socioeconomic aspects of medicine. Manuscripts with clinical and public

health implications and manuscripts with innovative ideas and/or

approaches that bridge different fields are considered with priority.

General Requirements

All

submitted manuscripts should contain original research that has not

been previously published partly or in full in print or electronic

format and are currently not under consideration for publication

elsewhere. Manuscripts from any country are welcome, but must  be

written in English. JBR also publishes reviews which are mainly by

invitation. Original articles should summarize results of a complete,

rigorously designed study supported by experimental and/or clinical

data. The recommended length for a full-length article is 3,000 to 5,000

words, excluding abstract, references, tables, or figures. Case reports

are intended to shed light on unusual cases and promote knowledge about

unknown or novel disease processes or manifestations, which help

contribute to a better understanding of such diseases, or provide

up-to-date knowledge about rare and uncommon diseases. Submissions

should not normally exceed 2,000 words or three published pages

including figures, diagrams and references. Letter to the Editor is

usually written to comment on a current controversial issue or express

the viewpoint of the writer, and it should be limited to 2,000 words.

Details of Submission Requirements

A

cover letter from the corresponding author must accompany the

manuscript and should briefly describe what is known in the field, the

conceptual advances provided by and the significance of the reported

findings. The authors are encouraged to suggest appropriate reviewers

and are permitted to make a request for exclusion of up to three

reviewers. Cover letter should state that the submitted material is

original research, has not been previously published, and has not been

submitted elsewhere while under review by JBR. The cover letter is

confidential and will not be sent to the reviewers. The cover letter

should contain the names of all the authors and their complete mailing

addresses and identify the correspondence author.

Manuscript Components

Manuscript

should be arranged in the following order: (a) Title section, including

Title, Running Title, Authors, Author Affiliations, and Correspondence;

(b) Abstract; (c) Keywords; (d) Introduction; (e) Materials and

Methods, (f) Results; (g) Discussion; (h) Footnotes, including

acknowledgment and abbreviations; (i) References; (j) Figure legends;

(k) Tables; (l) Figures; (m) Supplemental data.

Text

components of the manuscript (a-j) should be prepared using Microsoft

Word in 12 pt with one point five line-space on one side of A4 (297×210

mm) sheets with all pages numbered. Tables (k) should be prepared in

Microsoft Word with single space. Figures (l) should be converted to JPG

format. The manuscript can be submitted through the online submission

system (http://www.jbr-pub.org.cn/).

Research Article Format

Title

The title should be informative and concise, and reflect the content of

the article in terms understandable to a broad readership. It should be

no longer than 150 characters (including spaces) and contain no

non-standard acronyms or abbreviations.

Running

title A running title that describes the key meaning of the paper

should be provided and kept within 60 characters (including spaces).

Authorship

Author names should be spelled out in full, with the given name first

and the family name last. Affiliations (including department/subunit,

institution, city, province/state/region, postal code and country or

region) should be provided for each author. If the authors are

affiliated to different units, the affiliation sequence should follow

the order of the author list, marked with superscript using a, b, and c,

etc. following author names. Corresponding author's name, full postal

address, telephone and fax numbers and e-mail address should be

provided. Any change in authorship after submission must be approved in

writing by all authors.

Abstract

An unstructured abstract consisting of a single paragraph of no more

than 150 words is recommended including the purpose of the study or the

reason why you intended to do the study, the main methods used in the

study, and main data or outcomes, as well as a conclusion in a definite,

conclusive, and short statement, but not indefinite, vague, or

suggestive sentences. The abstract must be informative rather than

indicative. Authors should emphasize the new and important aspects of

the study.

Keywords

Up to six key words, separated by commas, are allowed. They should be

taken from those recommended by the Index Medicus Medical Subject

Headings (MeSH) browser list at

http://www.nlm.nih.gov/mesh/meshhome.html.

Introduction

The Introduction summarizes the rationale for the study and mainly

includes the background of the research through literature citation, the

questions to be addressed, the objectives of the research, and the main

methods used.

Materials and Methods

Materials

Reagents:

The names of the suppliers for reagent or kit used in the research

should be given along with the country of the supplier (e.g.,

FITC-conjugated rat anti-goat IgG was purchased from Santa Cruz

Biotechnology, USA.).

Drug

Names: The Recommended International Non-proprietary Name (RINN) should

be used for medicinal substances unless the specific trade name of a

drug is directly relevant to the discussion.

Species

nomenclature: The scientific name [genus, species (in italics) and

authority] for all microorganisms and animals should be given. Simple

chemical names may be used in certain places, for example, CO2.

Experimental

subjects: The grade of the animals used should be indicated and the

certificate number of the animal breeder provided. Rats and mice of at

least Grade II can be reported. The sex, age, and body weights of tested

animals or humans should be expressed as mean, standard deviation, and

total range.

Ethical

considerations: When reporting experiments on human subjects or

animals, authors should include an ethical statement in the Materials

and Methods section. Authors should indicate whether the procedures

followed were in accordance with the ethical standards of the

responsible committee on human experimentation (institutional and

national) and with the Helsinki Declaration. Human experiments may be

performed only in accordance with the ethical standards provided by the

responsible committee of the institution at which the work was carried

out and in accordance with the Declaration of Helsinki (as revised in

Edinburgh 2000), available at http://www.wma.net/. If doubt exists

whether the research was conducted in accordance with the Helsinki

Declaration, the authors must explain the rationale for their approach

and demonstrate that the institutional review board explicitly

approved   the doubtful aspects of the study. The patients' names,

initials, or hospital names or any information that may lead to the

identification of the patients should be omitted. Animal experiments

should follow the guidelines for the care and use of animals established

by  the authors' affiliated institution(s). For enrolled subjects, each

should voluntarily sign an informed consent based on the full

understanding of the research. When researches were conducted on

animals, authors should indicate whether the institutional and national

guidelines for the care and use of laboratory animals were followed.

Methods

should be described in sufficient detail so that other laboratories can

reproduce the results and verify the claims. Generally, standard

procedures should be referenced, but significant modifications should be

described. Appropriate experimental design and statistical methods

should be supplied and described wherever necessary for proper

interpretation of data and verification of claims. All novel materials

and procedures should be described in sufficient detail to allow their

reproduction (e.g., DNA constructs, genetic stocks, enzyme preparations,

and analytical softwares).

Units

Please use the metric system for the expression of length, height,

weight, mass, area and volume. Temperatures are to be given in degrees

Celsius (°C). Use of Systeme International (SI) units is preferred for

all hematological and clinical chemistry measurements. Quantities,

units, and numerical values (see ISO 31-0: 1992)

SI

units (Système International d'Unités) should be used. For example:

25.4 mm (not 1 inch), mol/L (not M or N). When an Arabic number precedes

a SI unit, the unit full name should be used, for example, 1 second, 2

minutes, 3 hours, 4 days, day 4 (the fourth day), 5 years, year 5 (the

fifth year). The symbol ‰ (“per mill” or per thousand) should be

avoided. Abbreviations such as ppm and ppb should not be used. No unit

is required for relative molecular mass. A solidus (/) should not be

followed by a multiplication sign or  a division sign unless parentheses

are inserted to avoid any ambiguity. In complicated cases, negative

powers or parentheses should be used, for example, mol/(L·s), not

mol/L/s. Multiple prefixes (e.g., mμg) should not be used.

Dosage

is expressed as per kg except in mice. Concentration in solution is

expressed as per L, not per mL. Values for rpm should be converted into

gravity (×g). Absorbance (A) values are preferred to optical density

(OD) values.

Symbols

are not pluralized (e.g., 7 kg, not kgs). The numerical value such as

the ratio of the quantity to the unit (e.g., λ/nm = 589) should be

indicated. This is particularly useful in graphs and in the headings of

columns in tables.

Use 12.4 mm (not 0.0124 m), 5 μmol (not 5×10-6 mol), 3-8 g, 3%-8%, 3 m×8 m×2 m, 8 ± 3 g, and (8 ± 3) nmol/L.

Do

not include more digits than are justified by the accuracy of the

determinations. For example: a dog weighs 9 kg (not 9000 g, which

implies an accuracy of 1 g). In a sample, the number of significant

figures is determined by the variation within the sample, that is,

one-third of the standard deviation. For example: 8.6 ± 2.9 kg (not 8619

± 2930 g, nor 9 ± 3 kg). The sign for multiplication of numbers is a

cross (×) or a raised dot (·). Leave a space between the numerical value

and the unit symbol, e.g., 56°C. Calendar dates may be written in the

following format: 5 June, 2006.

For

isotopically labelled compounds, use a square bracket directly attached

to the front of the name (word) or formula. Examples:

[14C]urea,

[α-32P]ATP (not AT32P), sodium [14C] formate. However, both

[131I]iodoalbumin and 131I-albumin are correct. Results Emphasize or

summarize only important observations. Simple data may be set forth in

the text with no need for tables or figures. Results can be described

using text, tables and figures. The text should complement the materials

given in the Tables and/or Figures, and should not be simple, direct

repetition of the information in the Tables and/or Figures. Please

provide full details of statistical analysis either in the text or in

the Tables and/or Figure legends. Please include the type of test, the

precise data to which it was applied, the value of the relevant

statistics, the sample size and/or degrees of freedom, and the

probability level.

Discussion

The main purpose of the Discussion is to comment on the significance of

the results and set them in the context of previous work. Emphasize any

new and important findings and relate your results to other studies.

Discuss the limitations of your experiments. Hypothesis should be

rational and evidence-based. Please avoid repeating information in the

Results section.

Acknowledgments

may briefly include 1) contributors that do not warrant authorship; 2)

technical help; 3) material support. Abbreviations Any abbreviations

should be defined on first usage in the text. Use SI units only.

However, some common names, such as GTP, RNA and PCR, may not be

defined. All nomenclature, including gene names and symbols, should be

used in a scientifically accurate manner following the nomenclature

conventions adopted by the scientific community.

References

References, which should be no more than 35 for original research and

no more than 10 for Letter to the Editor and case report, must be

numbered consecutively in the order of appearance in the text, and

listed in numerical order in the reference list.

Each

reference citation within the main body of the text should be indicated

by a superscript Arabic number in square brackets. Authors are

responsible for the accuracy and completeness of their references and

correct citation in the text. Please pay particular attention to the

content, year, volume, page and so on. Journal titles should be

abbreviated in accordance with the Index Medicus (www.nlm.nih.gov). The

names of all the authors are listed if three or fewer, followed by their

initials, and, if there are more than three authors, only the first

three authors are listed followed by et al. References published within

the past five years are preferred. Do not cite uncompleted work or work

that has not yet been accepted for publication as references. All

references should be presented using the following format:

Journal articles in English:

[1]

Manabe YC, Clark DP, Moore RD, et al. Cryptosporidiosis in patients

with AIDS: correlates of disease and surival[J]. Clin Infect Dis,

1998,27(3):536-542.

[2]

Moisan M, Barbeau J, Moreau S, et al. Low-temperature sterilization

using gas plasmas: a review of the experiments and an analysis of the

inactivation mechanisms[J]. Int J Pharm, 2001,226(1-2):1-21.

[3]

Steube KG, Meyer C, Drexler HG. Constitutive protein expression of

monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and

regulation of the secretion by anti- and proinflammatory stimuli[J].

Leuk Res, 1999,23(9):843-849.

Articles not in English:

[1]

Chachin M, Ohmura T, Hayashi N, et al. Pharmacological and clinical

profile of telmisartan, a selective angiotensin II type-1 receptor

blocker[J]. NipponYakurigaku Zasshi (in Japanese), 2004,124(1):31-39.

Volume with supplement:

Avis NE, Deimling GT. Cancer survivorship and aging[J]. Cancer, 2008,113(S12):3519-3529.

Volume with parts:

Ozben

T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin

dependent diabetes mellitus[J]. Ann Clin Biochem, 1995,32(Pt3):303-306.

Books:

Levinsky

NG. Fluid and electrolytes. In: Thorn GW, Adams RD, Braunwald E,

Editors. Harrison's Principles of Internal Medicine, 8th edition. New

York: McGraw-Hill, 1977:364-375.

Tables

Tables should be a three-line graph and cited consecutively in the

text. All numbers should be written in the same decimal place. Not

applicable data should be represented by a “-”. Pay attention to the

difference between “zero” and “not done” as an entry in the table.

Tables also should be practically self-contained and self-explanatory.

All tables should be cited in the text and numbered consecutively with

Arabic numerals. Ensure that all symbols or abbreviations are explained.

Label each table at the top with an Arabic numeral followed by the

table title. Insert explanatory material and footnotes below the table.

Designate footnotes using lowercase superscript letters (a, b, c)

reading horizontally across the table. Abbreviations that are used in a

table should be defined in the footnotes. Please prepare the tables in

MS Word with a single-space format. Do not embed tables as graphic

files, document objects, or pictures.

Figures

Figures (graphs, charts, photographs, and illustrations) should be

practically self-explanatory and labeled professionally. Dimensional

drawings and diagrams should include only the essential details with as

little lettering as possible. The magnification for micrograph should be

indicated by scale bars, inscriptions should be legible, and the

symbols and letters should be consistent among the panels. Figures

should be explained in the text, and should appear in the order cited.

Each figure should be a single file. Photographs must be of the highest

quality with good contrast. Color photographs are welcome.

Photomicrographs should be cropped to show only the essential parts and

an inset at higher magnification is usually more informative than a

single large one. Scale bars (e.g., 1 mm) should be put inside the

photomicrographs. For initial submission, JPG format is preferred.

Adequate figure resolution is essential to a high-quality print of your

paper. Raster line art should carry an absolute minimum resolution of

600 dpi, and for grey scale and color artworks, a minimum resolution of

300 dpi is required.

Figure

legends The legends should be typed below the reference of the

manuscript. Staining methods and magnification should be indicated for a

graph of tissue sections. Every figure should contain a title, and the

figure legend should follow the  title closely and provide enough

information to make the figures understandable without frequently

referring to the text. Do not describe methods in figure legends unless

they are necessary for interpreting the results conveyed by the figure.

All symbols and abbreviations that are used in the figure should be

defined in the legends.

Supplemental

Materials Supplemental materials that are directly related to the

conclusion are welcomed. However, unrelated data may be removed by

editors. Depending on the nature of supplemental data, they can be in

plain text, MS Word, MS Excel, JPEG, TIFF, and video. We encourage

authors to submit supplemental documents in PDF format if applicable.

Potential Conflicts of Interest

Authors

are responsible for disclosing all financial and personal relationships

that might bias their work. Authors should state explicitly whether

potential conflicts do or do not exist in the manuscript on a

conflict-of-interest notification page that follows the title page,

providing additional detail, if necessary, in a cover letter that

accompanies the manuscript.

Letters to the Editor

The

Journal accepts Letters to the Editor, which report original data or

may discuss published articles. Submission requirements for Letters are

the same as for regular manuscripts. Letters should be less than 1000

words in length, and cannot include more than eight references and two

figures (including tables). A single Figure or Table can be made but

should contain no more than 8  separate panels labeled from (a) to (h).

One panel may be composed of multiple figures with annotation around

individual panels to make viewing easier. An abstract and subheadings

should not be included in Letters. All letters to the Editor are subject

to editing and possible abridgement. The number of references for

Letter to the Editor should be no more than eight.

Reporting clinical Trials

Randomized

controlled trials should be presented according to the CONSORT

guidelines. At manuscript submission, authors must provide the CONSORT

checklist accompanied by a flow diagram that illustrates the progress of

patients through the trial, including recruitment, enrollment,

randomization, withdrawal and completion, and a detailed description of

the randomization procedure.  The CONSORT checklist and template flow

diagram can be found on http://www.consort-statement.org.